CagriSema is sold here for laboratory research, in 3 sizes (2.5mg + 2.5mg (5mg total) to 10mg + 10mg (20mg total)), starting at $75.00 a vial. Every batch arrives with a certificate naming the test that identified it, the test that measured its purity, and the date each was run. It is not an FDA-approved medicine. Research use only, and never for people or animals.
CagriSema specifications
| Product name | CagriSema |
|---|---|
| Also sold as | cagrilintide semaglutide, cagrilintide and semaglutide blend |
| Physical form | Freeze-dried powder — a solid cake in a sealed vial |
| Appearance | White to off-white cake |
| Sizes on this page | 2.5mg + 2.5mg (5mg total) · 5mg + 5mg (10mg total) · 10mg + 10mg (20mg total) |
| Purity specification | ≥99% by RP-HPLC. The number for the lot you receive is whatever its own certificate says. |
| Identity check | Mass spectrometry, read against the mass this compound should have |
| Net content | Weighed per lot and reported separately from purity |
| Lot documentation | At the laboratory — each certificate posts here the day it clears |
| Storage | Sealed, cold and out of the light |
| Ships from | Santa Ana, California — same business day on verified in-stock orders placed before 12 PM Pacific |
| Intended use | Laboratory research only. Not for human or animal use. |
What is CagriSema, and what is it used for?
CagriSema is also listed and searched as cagrilintide semaglutide, cagrilintide and semaglutide blend. They all mean the same blend. A name is not a test, which is why the lot record further down counts for more than the wording on a label.
The vial holds Cagrilintide, Semaglutide freeze-dried together. Each component has its own formula and its own record; the certificate for this lot reports on the mixture as sold.
A fixed-combination product name covering two separate molecules: cagrilintide, a long-acting amylin analogue, and semaglutide, a GLP-1 analogue.
Two distinct mechanisms in one product. Cagrilintide acts non-selectively at calcitonin family receptors — the amylin receptors and the calcitonin receptor. Semaglutide acts at the GLP-1 receptor. The combination rationale is that amylin and GLP-1 signalling act through different pathways and are proposed to be additive.
Investigational combination, developed by Novo Nordisk. The two components each have their own separate literature.
No approved product. Nothing here is a single molecule, and the properties of the combination are not the sum of the components.
CagriSema for sale: 2.5mg + 2.5mg (5mg total), 5mg + 5mg (10mg total) and 10mg + 10mg (20mg total) vials, price per mg
CagriSema cost, and CagriSema price per mg by size
CagriSema is sold in 3 sizes here, 2.5mg + 2.5mg (5mg total), 5mg + 5mg (10mg total) and 10mg + 10mg (20mg total), from $75.00 a vial. CagriSema cost starts at that figure for the smallest vial, and the CagriSema price per mg in the second column is the number to compare between sizes. The per-mg column is the honest comparison between sizes; the two tier columns show what ten and twenty vials of one size bill at, because the volume discount is per size and mixed sizes do not combine.
| Size | One vial | Per mg | 10 vials −10% | 20 vials −15% | Availability |
|---|---|---|---|---|---|
| CagriSema 2.5mg + 2.5mg (5mg total) | $75.00 | $15.00 | $675.00$13.50/mg | $1,275.00$12.75/mg | Backordered — waitlist |
| CagriSema 5mg + 5mg (10mg total) | $145.00 | $14.50 | $1,305.00$13.05/mg | $2,465.00$12.32/mg | Backordered — waitlist |
| CagriSema 10mg + 10mg (20mg total) | $150.00 | $7.50 | $1,350.00$6.75/mg | $2,550.00$6.38/mg | Backordered — waitlist |
CagriSema discounts: bulk pricing, Subscribe & Save, and codes
Three things move this price and nothing else does: how many vials of one size are on the order, whether that order repeats, and one code. The fourth column prices each route against the 2.5mg + 2.5mg (5mg total) vial.
| Buying option | Takes off | When it applies | 2.5mg + 2.5mg (5mg total) at this option |
|---|---|---|---|
| One vial, one time | — | Any order | $75.00 |
| 10–19 vials of one size | 10% | This order | $675.00$67.50 a vial |
| 20 vials of one size | 15% | This order | $1,275.00$63.75 a vial |
| Subscribe, every 1 month | 6% | Shipment 2 onward | First $75.00, then $70.50 |
| Subscribe, every 2 months | 4% | Shipment 2 onward | First $75.00, then $72.00 |
| Subscribe, every 3 months | 2% | Shipment 2 onward | First $75.00, then $73.50 |
| 10 vials on a monthly subscription | 10%, then 6% more | Shipment 2 onward | First $675.00, then $634.50 |
| Sign-up code | 10% of the order | One use, dead 24 hours after signup | $67.50 for one vial |
| Friday newsletter code | 5% of the order | Live 24 hours, a new one each Friday | $71.25 for one vial |
| On-site offer code | 5% of the order | Live 30 minutes from when it appears | $71.25 for one vial |
| Free standard shipping | The shipping charge | Orders over $200 | 3 vials |
The first three stack; the codes do not. A volume discount comes off the line, a subscription cadence comes off that same line from shipment 2, and one code comes off what is left. One code per order, never two. A subscription runs a minimum of two shipments and can be cancelled once the second has shipped, and the first shipment always bills at today's eligible price with no cadence discount on it. The lowest this record ever bills is $11.98 per mg: twenty 2.5mg + 2.5mg (5mg total) vials on a monthly subscription, from shipment 2 onward.
Every figure above is what you pay; nothing is added at checkout — dispatch and delivery work the same on every order.
Where to buy CagriSema: five checks before you order from anyone
Where to get CagriSema, and how to buy CagriSema online
CagriSema for sale, or CagriSema peptide for sale, means this page: one record, 3 sizes, a lot certificate for each. You can buy CagriSema online here with guest checkout; verified in-stock orders placed before 12 PM Pacific are dispatched the same day.
Run these on us too. A supplier who cannot pass them is asking you to take their word for it, and their word is the one thing a certificate exists to replace.
- Check the certificate on the lab’s own site, not ours.
- See whether it was written for the seller.
- Match the lot number on the paper to the one on the vial.
- Look for a method and a date next to every number.
- Make sure identity was tested, not assumed.
Each of those is worked through, with what a failed check actually looks like, on verifying a certificate.
Cagrilintide and Semaglutide: the blend, and each on its own
CagriSema is a blend name, not a molecule, written Cagrilintide and Semaglutide as often as CagriSema. What the vial holds is the components below, and each of them is documented on its own record with its own certificate. The name is not standardised between suppliers, so two vials called CagriSema from two sellers can hold different amounts, which is why the certificate matters more than the label.
| Record | Class | Formula | Avg. mass | Sizes here |
|---|---|---|---|---|
| CagriSema | A fixed-combination product name covering two separate molecules: cagrilintide, a long-acting amylin analogue, and semaglutide, a GLP-1 analogue. | blend of 2 | — | 2.5mg + 2.5mg (5mg total) · 5mg + 5mg (10mg total) · 10mg + 10mg (20mg total) from $75.00 |
| Cagrilintide | Lipidated long-acting analogue of amylin (islet amyloid polypeptide). | C194H312N54O59S2 | 4409 | 2mg · 5mg · 10mg from $60.00 |
| Semaglutide | A peptide that works on the GLP-1 receptor. | C187H291N45O59 | 4114 | 5mg · 10mg · 15mg · 20mg · 30mg from $80.00 |
CagriSema guides and documentation
Written to answer the questions that come up around CagriSema specifically — what its paperwork should show, how it is handled, and how to judge a supplier selling it.
- CagriSema certificate of analysis: reading a two-peptide blend
- CagriSema Identity Testing: How It Is Confirmed
- CagriSema Storage and Stability in the Laboratory
The full library, grouped by what you came to answer, is in the laboratory guides.
The CagriSema certificate: lot, purity, identity, and how to verify it
A certificate answers identity, purity and net content as three separate questions, each with the method that produced it and the date it was run — how to read one covers what each field does and does not cover.
The certificate below belongs to one lot, and its number matches the one printed on the vial you receive. A real report for a different batch is still the wrong report.
| Size | Lot | Identity method | Purity | Test date |
|---|---|---|---|---|
| 2.5mg + 2.5mg (5mg total) | Pending verification | Pending verification | Pending verification | Pending verification |
| 5mg + 5mg (10mg total) | Pending verification | Pending verification | Pending verification | Pending verification |
| 10mg + 10mg (20mg total) | Pending verification | Pending verification | Pending verification | Pending verification |
No lot documentation is published for CagriSema yet. Rather than display a placeholder certificate, this record shows the gap until each field has been verified against the lot in hand. The certificate index lists every lot the moment its report clears.
Solution arithmetic for the bench, with no administration guidance: the vial concentration calculator, preset to CagriSema.
Where the FDA stands on CagriSema
The FDA has not approved this compound for anything, and nothing in this catalogue is a medicine. Where a compound stands legally depends on what it is, what form it is in, what it is being used for and which country you are in, and it changes over time, so the status shown here carries the date it was last checked.
Status verified 2026-08-25. Regulatory positions move; check the primary source before relying on any summary, including this one.
It is sold here as laboratory material under the research-use restriction that closes this page, which is not an approval, and not a statement that the compound is safe, effective or right for any purpose.
CagriSema research: what the published studies examine
Status: No FDA-approved application. This compound is sold as laboratory material. Where research on it has been published, it sits at the animal, cell or early-human stage, and this record does not summarise what it found. A supplier is not a neutral judge of evidence about its own catalogue.
CagriSema is not a molecule, it is two of them: cagrilintide and semaglutide co-formulated. Each acts on a different receptor system — cagrilintide across the calcitonin receptor family, semaglutide at the GLP-1 receptor — and the rationale for pairing them is that amylin signalling and GLP-1 signalling are separate pathways proposed to add rather than overlap. There is published evidence that targeting amylin receptors has the potential to act additively with GLP-1 receptor agonists, so the rationale is not invented.
But it remains a rationale: a pharmacological argument for why a combination should work is a hypothesis, and it is the kind of argument that reads like evidence without being any. Each component is documented on its own record, and for a research vial the more practical point is analytical: a two-component product requires a certificate that resolves each component separately by identity and quantity, which is a harder problem than a single-compound assay and one that some laboratories report only as a total.
| Reported observation | Model | Source |
|---|---|---|
| Reviewing the receptor pharmacology of AM833 (cagrilintide), the authors note increasing evidence that targeting the amylin receptors improves weight control and has the potential to act additively with other treatments such as GLP-1 receptor agonists — the stated basis for combining the two mechanisms. | recombinant receptor pharmacology across 25 endpoints | Fletcher and colleagues, AM833 is a novel agonist of calcitonin family G protein-coupled receptors: pharmacological comparison with six selective and nonselective agonists, Journal of Pharmacology and Experimental Therapeutics (2021)This supports the RATIONALE for combining. It is not a study of the combination. |
| The semaglutide component is a GLP-1 analogue differing from human GLP-1 at two positions with a fatty diacid at lysine 26, with reported GLP-1 receptor affinity of 0.38 nM and a plasma half-life of 46.1 hours in mini-pigs. It does not cross the blood-brain barrier, reaching central sites through the circumventricular organs. | receptor binding and mini-pig pharmacokinetics | Lau and colleagues, Discovery of the once-weekly glucagon-like peptide-1 (GLP-1) analogue semaglutide, Journal of Medicinal Chemistry (2015) |
Open questions. The most useful thing to know is that no published receptor-level or preclinical study characterises this pair as a combination — the evidence cited above is for each component separately, plus a stated expectation of additivity. Combination pharmacology is not the sum of its parts: two compounds sharing a vial can interact through shared clearance, altered stability in solution, or overlapping tolerability, and the gastrointestinal effects characteristic of both mechanisms are the obvious place for that to show. CagriSema is investigational and approved nowhere.
This page does not reproduce clinical efficacy endpoints. That is a deliberate and consistent choice across every incretin compound on this catalogue: those results describe a supervised therapy given to patients under medical care, which is a different thing from laboratory material, and printing them beside a purchase control would blur that distinction rather than inform anyone. Tolerability findings from the same trials are reported, because how often a compound causes adverse events is a property of the compound.
Finally, the point that applies to every reseller including this one: a vial bearing one of these names is related to the developed molecule by claimed sequence identity alone, and that claim is exactly what an identity assay on the specific lot exists to test.
Each row above describes an observation in the stated model. None of it describes what CagriSema would do in a person or an animal outside that model, and none of it is a recommendation to use it for anything.
Questions about CagriSema
Where to buy CagriSema Peptide, and can I get it online?
How much does CagriSema Peptide cost?
What is the cheapest way to buy CagriSema Peptide?
What is the FDA approval status of CagriSema?
What is CagriSema used for?
Is CagriSema legal?
What is CagriSema peptide, and what is in a vial?
How does CagriSema work, and what does it do?
How does CagriSema work?
What is CagriSema peptide?
Is CagriSema fda approved?
How do I verify the certificate of analysis is real?
FOR LABORATORY AND IN-VITRO RESEARCH USE ONLY. NOT FOR HUMAN OR ANIMAL CONSUMPTION. NOT FOR PERSONAL, MEDICAL, DIAGNOSTIC, THERAPEUTIC, OR RECREATIONAL USE.
